Respicardia Receives $10,000,006 Series D Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a3659db-9065-4d14-b7d0-a5857608b499
Date 9/5/2013
Company Name Respicardia
Mailing Address 12400 Whitewater Dr Minnetonka, MN 55343
Company Description Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.